Autor segons l'article: Julve, Josep; Genua, Idoia; Quifer-Rada, Paola; Yanes, Oscar; Barranco-Altirriba, Maria; Hernandez, Marta; Junza, Alexandra; Capellades, Jordi; Granado-Casas, Minerva; Alonso, Nuria; Castelblanco, Esmeralda; Mauricio, Didac
Departament: Enginyeria Electrònica, Elèctrica i Automàtica
Autor/s de la URV: Junza Martínez, Alexandra / Yanes Torrado, Óscar
Paraules clau: Type 1 diabetes Translational research Mice Mass-spectrometry Lipid metabolism Impaired insulin signaling Fatty acids Cholesterol
Resum: Aims: To uncover novel candidate metabolomic and lipidomic biomarkers in newly-diagnosed type 1 diabetes (T1DM) after achieving optimal glucose control.Methods: Comprehensive lipidomic and metabolomic analysis was performed in serum of 12 adults with T1DM at onset and after achieving optimal glycemic control (HbA1c < 7 %) (after 2-6 months). Results: After intensive therapy, subjects (mean age 25.2 years, 58.3 % men) showed decreases in blood glucose (p < 0.001), HbA1c [11.5 % (9.2-13.4) to 6.2 % (5.2 - 6.7); p < 0.001] and changes in 51 identified lipids. Among these changes, we found that triglycerides (TG) containing medium chain fatty acids (TG45:0, TG47:1), sphingomyelins (SM) (SM(d18:2/20:0), SM42:4)), and phosphatidylcholines (PC) (PC(O-26:2), PC(O-30:0), PC (O-32:0), PC(O-42:6), PC(O-44:5), PC(O-38:3), PC(O-33:0), PC(O-46:8), PC(O-44:6), PC(O-40:3), PC(O-42:4), PC (O-46:7), PC(O-46:6), PC(O-44:5), PC(O-42:3), PC(O-44:4)) decreased; whereas PC(35:1), PC(37:1) and TG containing longer chain fatty acids (TG(52:1), TG(55:7), TG(51:2), TG(53:3), TG52:2), TG(53:2), TG(57:3), TG (61:3), TG(61:2) increased. Further, dihydro O-acylceramide (18:1/18:0/16:0), diacylglycerophosphoethanol-amine (PE(34:1)), diacylglycerophosphoinositol (PI(38:6), and dihydrosphingomyelins (dihydroSM(36:0), dihydroSM(40:0), dihydroSM(41:0), dihydroSM(42:0)) increased. Uric acid, mannitol, and mannitol-1-acetate levels also increased.Conclusions: Our data uncovered potential favorable changes in the metabolism of glycerophospholipids, glyc-erolipids, and sphingolipids in new-onset T1DM after achieving optimal glycemic control. Further research on their potential role in developing diabetes-related complications is needed.
Àrees temàtiques: Saúde coletiva Psicología Odontología Nutrição Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Internal medicine Interdisciplinar Farmacia Engenharias iv Enfermagem Endocrinology, diabetes and metabolism Endocrinology & metabolism Endocrinology Educação física Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciência de alimentos Biotecnología
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: oscar.yanes@urv.cat alexandra.junza@urv.cat
Identificador de l'autor: 0000-0003-3695-7157 0000-0001-7205-0419
Data d'alta del registre: 2024-10-12
Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
Enllaç font original: https://www.sciencedirect.com/science/article/abs/pii/S0168822723000530
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Diabetes Research And Clinical Practice. 197 110578-
Referència de l'ítem segons les normes APA: Julve, Josep; Genua, Idoia; Quifer-Rada, Paola; Yanes, Oscar; Barranco-Altirriba, Maria; Hernandez, Marta; Junza, Alexandra; Capellades, Jordi; Granad (2023). Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. Diabetes Research And Clinical Practice, 197(), 110578-. DOI: 10.1016/j.diabres.2023.110578
DOI de l'article: 10.1016/j.diabres.2023.110578
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2023
Tipus de publicació: Journal Publications
Repositori URV